Search Results - "Rozen, Paul"

Familial adenomatous polyposis by Half, Elizabeth, Bercovich, Dani, Rozen, Paul

“…Familial adenomatous polyposis (FAP) is characterized by the development of many tens to thousands of adenomas in the rectum and colon during the second decade…”
Get full text

Performance Characteristics and Evaluation of an Automated-Developed and Quantitative, Immunochemical, Fecal Occult Blood Screening Test by VILKIN, Alex, ROZEN, Paul, LEVI, Zohar, WAKED, Amal, MAOZ, Eran, BIRKENFELD, Shlomo, NIV, Yaron

“…Guaiac fecal occult blood colorectal cancer (CRC) screening tests (FOBT) are faulted for low sensitivity and nonspecificity for human hemoglobin (Hb)…”
Get full text

Familial adenomatous polyposis: The practical applications of clinical and molecular screening by Rozen, Paul, Macrae, Finlay

“…Familial adenomatous polyposis (FAP) is an autosomal dominant condition mostly due to a mutation of the APC gene on the chromosome 5q. Carriers have an almost…”
Get full text

The Jewish people: their ethnic history, genetic disorders and specific cancer susceptibility by Kedar-Barnes, Inbal, Rozen, Paul

“…The Jews are an ancient and unique group of people linked by language, religion and customs in spite of their major geographical shifts, expulsions, forced…”
Get full text

Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma by Rodriguez‐Bigas, Miguel A., Vasen, Hans F. A., Lynch, Henry T., Watson, Patrice, Myrhøj, Torben, Järvinen, Heikki J., Mecklin, Jukka Pekka, Macrae, Finlay, John, D. James B. St, Bertario, Lucio, Fidalgo, Paulo, Madlensky, Lisa, Rozen, Paul

“…BACKGROUND Small bowel carcinoma is uncommon. However, hereditary nonpolyposis colorectal carcinoma (HNPCC) patients are at increased risk of small bowel…”
Get full text

Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer by ROZEN, P, SHOMRAT, R, STRUL, H, NAIMAN, T, KARMINSKY, N, LEGUM, C, ORR-URTREGER, A

“…Background & Aims: Israeli Jews of European birth, i.e., Ashkenazim, have the highest colorectal cancer incidence of any Israeli ethnic group. The I1307K APC…”
Get full text

A quantitative immunochemical fecal occult blood test for colorectal neoplasia by Levi, Zohar, Rozen, Paul, Hazazi, Rachel, Vilkin, Alex, Waked, Amal, Maoz, Eran, Birkenfeld, Shlomo, Leshno, Moshe, Niv, Yaron

“…Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening are not specific for human hemoglobin and have low sensitivity…”
Get full text

Changing Epidemiology of Colorectal Cancer Makes Screening Sigmoidoscopy Less Useful for Identifying Carriers of Colorectal Neoplasms by Rozen, Paul, Liphshitz, Irena, Barchana, Micha

“…Background There is renewed interest in flexible sigmoidoscopy (FS) colorectal cancer (CRC) screening following trials showing significantly reduced CRC…”
Get full text

The changing epidemiology of colorectal cancer and its relevance for adapting screening guidelines and methods by Rozen, Paul, Liphshitz, Irena, Barchana, Micha

“…In many countries at risk for colorectal cancer (CRC), screening guidelines provide average-risk screening for patients aged between the ages of 50 and 75…”
Get full text

Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants by LEVI, Zohar, ROZEN, Paul, HAZAZI, Rachel, VILKIN, Alex, WAKED, Amal, MAOZ, Eran, BIRKENFELD, Shlomo, LIEBERMAN, Nicky, KLANG, Shmuel, NIV, Yaron

“…We evaluated the effect of the use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDS), and anticoagulants on the performance of immunochemical fecal…”
Get full text

355 The Changing Epidemiology of Colorectal Cancer Now Makes Screening Sigmoidoscopy Less Useful for Identifying Carriers of Colorectal Neoplasms by Rozen, Paul, Liphshitz, Irena, Barchana, Micha

Get full text

Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use by Rozen, Paul, Comaneshter, Doron, Levi, Zohar, Hazazi, Rachel, Vilkin, Alex, Maoz, Eran, Birkenfeld, Shlomo, Niv, Yaron

“…BACKGROUND: Quantified, human hemoglobin (Hb)‐specific, immunochemical fecal occult blood test (IFOBT) measurements are now used for colorectal cancer (CRC)…”
Get full text

Follow-up of patients undergoing both semiquantitated immunochemical fecal occult blood and colonoscopy examinations by Rozen, Paul, Liphshitz, Irena, Barchana, Micha

“…The semiquantitated immunochemical fecal occult blood test (I-FOBT) used for colorectal cancer (CRC) screening has had its long-term performance…”
Get full text

Report of the World Organization for Digestive Endoscopy Colorectal Cancer Screening Committee Meeting, Chicago, 2005 by Rozen, Paul

Get full text

Recommendations for a step‐wise comparative approach to the evaluation of new screening tests for colorectal cancer by Young, Graeme P., Senore, Carlo, Mandel, Jack S., Allison, James E., Atkin, Wendy S., Benamouzig, Robert, Bossuyt, Patrick M. M., Silva, Mahinda De, Guittet, Lydia, Halloran, Stephen P., Haug, Ulrike, Hoff, Geir, Itzkowitz, Steven H., Leja, Marcis, Levin, Bernard, Meijer, Gerrit A., O'Morain, Colm A., Parry, Susan, Rabeneck, Linda, Rozen, Paul, Saito, Hiroshi, Schoen, Robert E., Seaman, Helen E., Steele, Robert J. C., Sung, Joseph J. Y., Winawer, Sidney J.

“…BACKGROUND New screening tests for colorectal cancer continue to emerge, but the evidence needed to justify their adoption in screening programs remains…”
Get full text

The changing epidemiology of upper gastrointestinal cancers in Israel: clinical and screening implications by Rozen, Paul, Liphshitz, Irena, Barchana, Micha

“…Western countries and now developing countries have noted a decreasing incidence of upper gastrointestinal (UGI) (esophageal and gastric) cancers, but…”
Get full text

The changing incidence and sites of colorectal cancer in the Israeli Arab population and their clinical implications by Rozen, Paul, Rosner, Guy, Liphshitz, Irena, Barchana, Micha

“…Israeli Arabs have been at low risk for colorectal cancer (CRC) and had mainly proximal cancer, but increasing CRC is now noted. We examined this trend and CRC…”
Get full text

Choice of Fecal Occult Blood Tests for Colorectal Cancer Screening: Recommendations Based on Performance Characteristics in Population Studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report by Young, Graeme P, St John, James D B, Winawer, Sidney J, Rozen, Paul

“…There is now strong evidence that screening for colorectal cancer with fecal occult blood tests (FOBTs) is effective in reducing the incidence and mortality of…”
Get full text

Su1807 Can a Gastrointestinal Pathologist Identify Microsatellite Instability in Colorectal Cancer With Reproducibility & a High Degree of Specificity? by Rozen, Paul, Brazowski, Eli, Rosner, Guy, Samuel, Ziona, Solar, Irit, Rozner, Guy

Get full text

Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report by Young, Graeme P, John, D.James B.St, Winawer, Sidney J, Rozen, Paul

“…OBJECTIVE: There is now strong evidence that screening for colorectal cancer with fecal occult blood tests (FOBTs) is effective in reducing the incidence and…”
Get full text